Human Milk Oligosaccharides (HMOs) Market To Reach $1,660.0 Million by 2035

Human milk oligosaccharides (HMOs) market was valued at $480.0 million in 2025 and is projected to reach $1,660.0 million by 2035, expanding at a CAGR of 13.2% during the forecast period. Human Milk Oligosaccharides are complex carbohydrates naturally found in human breast milk and are increasingly used in infant nutrition, functional food & beverages, nutritional supplements, medical nutrition, and animal nutrition due to their prebiotic and immune-supporting properties.

Browse the full report description of “Human Milk Oligosaccharides (HMOs) Market Size, Share & Trends Analysis Report, By Product Type (Fucosylated HMOs, Neutral Core, Sialylated HMOs, Others), By Form (Powder, Liquid), By Application (Infant Nutrition, Functional Food & Beverages, Nutritional Supplements, Medical Nutrition, Animal Nutrition), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/human-milk-oligosaccharides-hmos-market

A major macro driver accelerating market growth is the rising global demand for infant nutrition products and scientifically backed functional ingredients. According to the World Health Organization, around 140 million babies are born globally each year, creating sustained demand for infant nutrition products. Additionally, exclusive breastfeeding rates remain below 50% globally, increasing dependence on fortified infant formulas. Regulatory approvals from the U.S. Food and Drug Administration and the European Commission for ingredients such as 2’-Fucosyllactose (2’-FL) and Lacto-N-neotetraose (LNnT) are supporting the commercialization of advanced infant formula and functional nutrition products. The Fucosylated HMOs segment is witnessing significant growth due to high commercial demand for 2’-FL and 3-FL in infant formula and supplements, while the Powder form dominates due to easier storage, transportation, and formulation stability.

Innovation Leaders Transforming the Human Milk Oligosaccharides (HMOs) Market

The key players in the human milk oligosaccharides (HMOs) market include DSM-Firmenich, FrieslandCampina Ingredients, BASF SE, Novonesis, and Kyowa Hakko Bio Co., Ltd., among others. These companies are driving innovation in the Human Milk Oligosaccharides (HMOs) market through the development of advanced HMO ingredients such as 2’-Fucosyllactose (2’-FL), Lacto-N-neotetraose (LNnT), 3’-Sialyllactose (3’-SL), and 6’-Sialyllactose (6’-SL) for applications in infant nutrition, functional food & beverages, nutritional supplements, and medical nutrition. Their strategies include expanding HMO product portfolios through research and development, regulatory approvals, partnerships, acquisitions, and geographic expansion to improve product accessibility, enhance gut health and immune-supporting benefits, and strengthen their presence across global early-life and functional nutrition markets.

• In April 2025, DSM-Firmenich received regulatory approval from the Food Safety and Standards Authority of India for its GLYCARE 2’-Fucosyllactose (2’-FL) Human Milk Oligosaccharide ingredient for use in infant nutrition products. This marked the company’s first HMO approval in India and strengthened its presence in the rapidly growing Asia-Pacific early-life nutrition market.
• In May 2025, BENEO and WACKER Chemie AG launched the Human Milk Oligosaccharide (HMO) 2’-Fucosyllactose (2’-FL) under a global strategic partnership. The launch strengthened HMO supply in the European market and enhanced early-life nutrition solutions for infant formula manufacturers.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• By Product Type
• By Form
• By Application
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape – DSM-Firmenich, FrieslandCampina Ingredients, BASF SE, Novonesis, and Kyowa Hakko Bio Co., Ltd., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Human Milk Oligosaccharides (HMOs) Market Report Segment

By Product Type

• Fucosylated HMOs
• Neutral Core
• Sialylated HMOs
• Others

By Form

• Powder
• Liquid

By Application

• Infant Nutrition
• Functional Food & Beverages
• Nutritional Supplements
• Medical Nutrition
• Animal Nutrition

Human Milk Oligosaccharides (HMOs) Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/human-milk-oligosaccharides-hmos-market